-
2024-520364-34-00
5
2026-02-23
Acute myocardial infarction
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2024-519369-24-00
5
2026-01-29
METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
-
2024-519494-19-00
5
2025-12-22
Nutritional and metabolic diseases
-
2025-521692-31-00
5
2025-12-19
Chronic Primary Immune Thrombocytopenia
-
2024-514401-54-00
5
2025-11-13
Chronic Primary Immune Thrombocytopenia
-
2024-519871-24-00
10
2025-11-11
Breast cancer
-
2024-516924-32-00
5
2025-10-17
Neovascular Age-Related Macular Degeneration (nAMD)
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-517972-39-00
5
2025-08-19
Autoimmune haemolytic anaemia
-
2024-515640-22-00
6
2025-08-06
polypoidal choroidal vasculopathy
-
2024-518893-15-00
5
2025-07-29
Chronic lymphotic leukemia and Small Lymphocytic lymphoma
-
2024-515098-93-00
5
2025-07-22
Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML
-
2024-519262-42-00
4
2025-07-15
NSCLC non-small cell lung cancer
-
2024-516162-11-00
5
2025-07-14
Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho
-
2024-516834-36-00
5
2025-07-08
Locally recurrent unresectable or metastatic TNBC with tumors expressi
-
2024-517247-31-00
5
2025-07-07
Newly Diagnosed Higher Risk Myelodysplastic Syndrome
-
2024-517789-41-00
6
2025-07-04
metastatic or locally advanced renal cell carcinoma
-
2024-512696-12-00
4
2025-06-24
BCR-ABL1+ Chronic Myeloid Leukemia
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2024-511495-32-00
5
2025-04-16
Chronic Phase Chronic Myeloid Leukemia
-
2024-515214-41-00
5
2025-03-27
advanced pancreatic cancer
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast